Olanzapine
NDC 69189-5510
Product Information
Olanzapine is a ANDA-approved product labeled by Avera Mckennan Hospital. Olanzapine is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder). It is supplied as a yellow product. This product entry covers the primary NDC 69189-5510 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
M;OE1
Code Structure Chart
Product Details
What is NDC 69189-5510?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- OLANZAPINE (UNII: N7U69T4SZR)
- OLANZAPINE (UNII: N7U69T4SZR) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ASPARTAME (UNII: Z0H242BBR1)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSPOVIDONE (15 MPA.S AT 5%) (UNII: 68401960MK)
- GUAR GUM (UNII: E89I1637KE)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MANNITOL (UNII: 3OWL53L36A)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 314155 - OLANZapine 5 MG Disintegrating Oral Tablet
- RxCUI: 314155 - olanzapine 5 MG Disintegrating Oral Tablet
* Please review the full disclaimer at the bottom of this page.